The White House has announced an additional $450 million in funding to combat the opioid crisis in the United States, with a particular focus on addressing the prevalence of Fentanyl.
This announcement comes as President Biden declared Overdose Awareness Week, emphasizing the administration's commitment to saving lives and tackling the overdose epidemic.
During a call with reporters, second gentleman Douglas Emhoff stated, "As we mark International Overdose Awareness Day, the Biden-Harris administration is taking action to beat the overdose epidemic and, more importantly, to save lives." Emhoff acknowledged the devastating impact of the crisis, noting that many families have lost loved ones and countless Americans have been affected by this "horrible epidemic."
The latest funding allocation will primarily support prevention and treatment efforts. Among the initiatives receiving funding are drug-free community coalitions aimed at keeping communities free from drugs.
Additionally, $1 million will be invested in an advertising campaign targeting young people. The funding also includes $279 million in grants from the Centers for Disease Control and Prevention (CDC) to expand "harm-reduction strategies" and provide life-saving care at the state and local level.
Opioids, particularly Fentanyl, have been responsible for over 100,000 overdose deaths in 2022. Fentanyl, primarily produced in Mexico using Chinese precursors, is then trafficked across the southern border. President Biden declared August 27 to September 2 as Overdose Awareness Week, emphasizing the nation's commitment to addressing the crisis and saving lives.
While opioid-related deaths have continued to rise in recent years, the administration has highlighted data suggesting a slowdown in overdose numbers, attributing it to its comprehensive drug strategy. Emhoff stated, "Because of the historic investments and the Biden-Harris administration, overdoses have flattened."
In addition to prevention and treatment efforts, the funding will also support substance use treatment and recovery services. Furthermore, an additional $19 million will be allocated to crack down on illicit drug trafficking in high-risk areas.
The administration has taken a multi-faceted approach to combatting the crisis, including targeting smugglers entering the U.S. The White House emphasized the FDA's approval of naloxone anti-overdose drugs, making them available over the counter.
Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy, emphasized the importance of ending the opioid crisis, stating, "Ending the opioid crisis is a key pillar of President Biden's unity agenda for the nation. And we are pushing forward to save as many lives as we can, as quickly as we can. The bottom line is this, that these actions will save lives."
The administration has faced criticism from Republicans regarding the Fentanyl crisis, particularly in relation to its handling of the situation at the southern border. Republicans argue that the administration's approach has exacerbated the flow of Fentanyl into the U.S. Some have even called for military action in Mexico to dismantle drug labs operated by cartels.
In response to these criticisms, the administration has emphasized its cooperation with Mexico, including the imposition of sanctions on cartel members and other actions aimed at addressing the crisis. The White House has pushed back against the criticism, highlighting its commitment to saving lives and addressing the opioid crisis from multiple angles.
Login